G. Kenneth Lloyd
Chief Tech/Sci/R&D Officer presso BEYONDSPRING INC.
Patrimonio netto: 145 088 $ in data 31/03/2024
Profilo
G.
Kenneth Lloyd is the founder of GKOL, Inc. He is currently the Chief Scientific Officer at BeyondSpring, Inc. Dr. Lloyd received his undergraduate and graduate degrees from McGill University and his doctorate from the University of Toronto.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BEYONDSPRING INC.
0.10% | 01/03/2023 | 40 641 ( 0.10% ) | 145 088 $ | 31/03/2024 |
Posizioni attive di G. Kenneth Lloyd
| Società | Posizione | Inizio |
|---|---|---|
| BEYONDSPRING INC. | Chief Tech/Sci/R&D Officer | 01/06/2015 |
Precedenti posizioni note di G. Kenneth Lloyd
| Società | Posizione | Fine |
|---|---|---|
| Dalian Wanchun Biotechnology Co. Ltd. | Chief Tech/Sci/R&D Officer | 01/01/2014 |
Nereus Pharmaceuticals, Inc.
 Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 29/04/2013 |
A.E. Wyeth & Co.
 A.E. Wyeth & Co. Miscellaneous Commercial ServicesCommercial Services Part of Vizards Staples & Bannisters, A.E. Wyeth & Co. is a legal services provider. The private company is based in Dartford, UK. A.E. Wyeth was acquired by Vizards Staples & Bannisters on July 11, 2001. | Chief Tech/Sci/R&D Officer | - |
| Sanofi SA | Corporate Officer/Principal | - |
Verne Mendel Medical Corp.
 Verne Mendel Medical Corp. Pharmaceuticals: MajorHealth Technology Verne Mendel Medical Corp. develops pharmaceutical product candidates to treat mitochondrial degenerative diseases. Its products include candidates treat neurodegenerative group diseases, such as Parkinson’s, Alzheimer’s, and Lou Gehrig’s; stroke, glaucoma, deafness, and inherited mitochondrial diseases; and metabolic group diseases, including diabetes, and its cardiac and neurologic complications. The company is headquartered in San Diego, CA. | Director/Board Member | - |
Formazione di G. Kenneth Lloyd
| McGill University | Graduate Degree |
| University of Toronto | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BEYONDSPRING INC. | Health Technology |
| Aziende private | 8 |
|---|---|
| Sibia Neurosciences, Inc. | Health Technology |
A.E. Wyeth & Co.
A.E. Wyeth & Co. Miscellaneous Commercial ServicesCommercial Services Part of Vizards Staples & Bannisters, A.E. Wyeth & Co. is a legal services provider. The private company is based in Dartford, UK. A.E. Wyeth was acquired by Vizards Staples & Bannisters on July 11, 2001. | Commercial Services |
Nereus Pharmaceuticals, Inc.
Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA. | Commercial Services |
| Wyeth-Ayerst Research | |
| Sanofi SA | Health Technology |
| GKOL, Inc. | |
Verne Mendel Medical Corp.
Verne Mendel Medical Corp. Pharmaceuticals: MajorHealth Technology Verne Mendel Medical Corp. develops pharmaceutical product candidates to treat mitochondrial degenerative diseases. Its products include candidates treat neurodegenerative group diseases, such as Parkinson’s, Alzheimer’s, and Lou Gehrig’s; stroke, glaucoma, deafness, and inherited mitochondrial diseases; and metabolic group diseases, including diabetes, and its cardiac and neurologic complications. The company is headquartered in San Diego, CA. | Health Technology |
| Dalian Wanchun Biotechnology Co. Ltd. |
- Borsa valori
- Insiders
- G. Kenneth Lloyd
